BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
Source: marketscreener.com
Recent Corporate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recent Corporate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recent Corporate Today - Breaking & Trending Today
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand - Enveric Biosciences (NASDAQ:ENVB)
Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the company continued to advance the development of the lead neuroplastogen drug candidate, EB-003, in preparation for an investigational new drug (IND) application and the expected initiation of a planned clinical development program," Joseph Tucker, Ph.D., director and CEO of Enveric, said. "EB-003 was designed specifically to address this major safety profile deficiency in...
Source: benzinga.com
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnin
Published Phase 1 data of SON-1010 in Frontiers in Immunology demonstrating the safety and tolerability of the F H AB-derived Interleukin 12 in healthy volunteersAnnounced early safety data from the company's Phase 1b/2a clinical trial of SON-080 in patients with chemotherapy-induced peripheral neuropathy (CIPN)Rece...
Source: pharmiweb.com
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-
Source: eagletribune.com